⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27720414 | 1.00 | — | — | |
| SCHEMBL2320554 | 1.00 | — | — | |
| SCHEMBL349126 | 0.72 | — | — | |
| SCHEMBL7526154 | 0.72 | LMNA (0.42) | — | |
| SCHEMBL31344344 | 0.72 | — | — | |
| SCHEMBL2791244 | 0.72 | — | — | |
| SCHEMBL11307245 | 0.72 | — | — | |
| SCHEMBL456619 | 0.72 | — | — | |
| SCHEMBL27607238 | 0.67 | — | — | |
| SCHEMBL2321370 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101460468-B | 2-pyrazinecarboxamide derivatives | HOFFMANN LA ROCHE | 2012-05-30 | — | — | CN | claimed |
| CN-101522626-A | 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as HDL-cholesterol raising agents | HOFFMANN LA ROCHE (CH) | 2009-09-02 | — | — | CN | claimed |
| CN-101460468-A | 2-pyrazinecarboxamide derivatives | HOFFMANN LA ROCHE (CH) | 2009-06-17 | — | — | CN | claimed |
| CN-101460468-B | 2-pyrazinecarboxamide derivatives | HOFFMANN LA ROCHE | 2012-05-30 | — | — | CN | disclosed |
| CN-101522626-A | 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as HDL-cholesterol raising agents | HOFFMANN LA ROCHE (CH) | 2009-09-02 | — | — | CN | disclosed |
| CN-101460468-A | 2-pyrazinecarboxamide derivatives | HOFFMANN LA ROCHE (CH) | 2009-06-17 | — | — | CN | disclosed |
| CN-101273026-A | Indane derivatives as MCH receptor antagonists | HOFFMANN LA ROCHE (CH) | 2008-09-24 | — | — | CN | disclosed |